Dapagliflozin Tetraacetate, Dapagliflozin matsakaici
Sunan Sinadari | Dapagliflozin Tetraacetate;Dapagliflozin matsakaici |
Makamantu | (2R,3R,5R,6R) -6-(Acetoxymethyl) -2- (4-chloro-3- (4-ethoxybenzyl) phenyl) tetrahydro-2H-pyran-2,3,4,5-tetrayl tetraacetate; [(2R,3R,4R,5S,6S) -3,4,5-triacetyloxy-6-[4-chloro-3-[(4-ethoxyphenyl) methyl] phenyl] oxan-2-yl] methyl acetate |
Lambar CAS | 461432-25-7 |
Tsarin kwayoyin halitta | C₂₉H₃₃ClO₀ |
Bayyanar | Fari zuwa Kashe-fari mai ƙarfi |
Matsayin narkewa | 180.7± 30.5 °C |
Nauyin Kwayoyin Halitta | 577.019 |
Adanawa | Yanayin rashin aiki |
Kashi | Matsayi;Pharmaceutical/API Drug Impurities/Metabolites; |
Aikace-aikace | Dapagliflozin Tetraacetate ya samo asali ne daga Dapagliflozin [D226255], mai hana sodium-glucose transporter 2. |
Magana | Kasichayanula, S. et al.: Ciwon sukari, Kiba da Metabolism 13, 47 (2011);Bernhardson, D. et al.: Org.Proc.Res.Dev., 18, 57 (2014); |
Sunan samfur:Dapagliflozin Tetraacetate, Dapagliflozin matsakaici, CAS NO: 461432-25-7
Makamantuwa:
Dapagliflozin Tetraacetate, Dapagliflozin matsakaici;
(2R,3R,5R,6R) -6-(Acetoxymethyl) -2- (4-chloro-3- (4-ethoxybenzyl) phenyl) tetrahydro-2H-pyran-2,3,4,5-tetrayl tetraacetate;
[(2R,3R,4R,5S,6S) -3,4,5-triacetyloxy-6-[4-chloro-3-[(4-ethoxyphenyl) methyl] phenyl] oxan-2-yl] methyl acetate;
(1s) -1,5-anhydro-1-c- (4-chloro-3- ((4-ethoxyphenyl)methyl) phenyl) -d-glucitoltetraacetate;
Acetic acid (2R, 3R, 4R, 5S, 6S) -3,4,5 - triacetoxy-6-[4-chloro -3- (4-ethoxy-benzyl) -phenyl] - tetrahydro-pyran-2-ylmethyl ester
(1S) -2,3,4,6-Tetra-O-acetyl-1,5-anhydro-1-[4-chloro-3- (4-ethoxybenzyl) phenyl]-D-glucitol
Dapagliflozin-A3
(1S) -1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl] phenyl]-D-glucitol tetraacetate
Anhui Cheer-Our Medical fasahar Co., Ltd da aka kafa a 2015. Bayan ci gaba forging gaba, kamfanin ya ci gaba a cikin wani high-tech Pharmaceutical sha'anin hadawa sinadaran da nazarin halittu miyagun ƙwayoyi bincike, Pharmaceutical matsakaici, APIs, shirye-shirye da kuma samfurin tallace-tallace.Ta hanyar bincike da haɓakawa da haɓakawa a fannin likitanci da kiwon lafiya kamar gama magunguna, APIs da masu tsaka-tsaki, kamfanin yana bin ka'idar abokin ciniki na farko, sabis na gaskiya, inganci na farko, fa'idar juna", ta hanyar cikakkiyar gwaji, inganci mai inganci. sabis, samar da al'ada kira, kwangila masana'antu da sarrafa ayyuka.
1. Duk wani tambaya ko sako za a amsa cikin sa'o'i 12.
2. Ƙwararrun masana'anta.Barka da zuwa ziyarci gidan yanar gizon mu.
3. API, Matsakaici suna samuwa, za mu iya bayar da Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwaƙwalwa na Ƙaddamarwa na Ƙaƙwalwa , da kuma rajista da kuma rajista.
4. Saurin isarwa.
5. Bayan-sale ayyuka